Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 39

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

593

HTML

4351

Figures (1-1)

208

Tables (1-2)

228

Sum=5380

Oct 21, 2005 (publication date) through Nov 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Oct 21, 2005; 11(39): 6165-6169
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6165

Figure 1 Fecal SCFAs in TEN patients. SCFA: short-chain fatty acids; Sb: Saccharomyces boulardii; 1P = 0.02 vs pre-treatment values.

Citation: Schneider SM, Girard-Pipau F, Filippi J, Hébuterne X, Moyse D, Hinojosa GC, Pompei A, Rampal P. Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J Gastroenterol 2005; 11(39): 6165-6169
URL: https://www.wjgnet.com/1007-9327/full/v11/i39/6165.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i39.6165